Terumo (TRUMY) to Release Quarterly Earnings on Friday

Terumo (OTCMKTS:TRUMY) will likely be announcing its results after the market closes on Friday, August 7th. Analysts expect Terumo to post earnings of $0.17 per share and revenue of $1.8372 billion for the quarter.

Terumo (OTCMKTS:TRUMY) last announced its quarterly earnings results on Friday, May 15th. The company reported $0.11 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.11. Terumo had a return on equity of 9.17% and a net margin of 12.09%.The business had revenue of $1.90 billion for the quarter, compared to analyst estimates of $1.84 billion. On average, analysts expect Terumo to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Terumo Price Performance

Shares of TRUMY opened at $14.45 on Thursday. The business’s fifty day moving average is $13.99 and its 200 day moving average is $13.54. Terumo has a 12-month low of $12.08 and a 12-month high of $19.60. The company has a quick ratio of 0.97, a current ratio of 1.59 and a debt-to-equity ratio of 0.06. The stock has a market cap of $21.32 billion, a P/E ratio of 23.70 and a beta of 0.68.

Analysts Set New Price Targets

TRUMY has been the topic of several research reports. Zacks Research upgraded shares of Terumo to a “hold” rating in a report on Thursday, April 9th. Nomura upgraded shares of Terumo from a “hold” rating to a “strong-buy” rating in a report on Thursday, July 30th. One equities research analyst has rated the stock with a Strong Buy rating and one has given a Hold rating to the company. Based on data from MarketBeat, Terumo has an average rating of “Buy”.

About Terumo

Terumo Corporation (OTCMKTS: TRUMY) is a Japan-based medical technology company that develops, manufactures and markets a broad range of healthcare products for hospitals, clinics and blood centers. Its businesses encompass cardiovascular systems, general hospital products and blood management and cell technologies, supplying devices used in interventional and surgical procedures as well as everyday clinical care. Terumo sells consumables and capital equipment intended to support patient care across acute and ambulatory settings.

Key product categories include vascular access and interventional devices (such as guidewires, catheters and delivery systems), cardiac and cardiopulmonary surgical equipment, infusion therapy products (including infusion pumps and disposables), syringes and blood bags.